MetLife Investment Management’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$293K Hold
33,168
﹤0.01% 2015
2025
Q4
$394K Sell
33,168
-1,377
-4% -$18.2K ﹤0.01% 1908
2025
Q3
$487K Hold
34,545
﹤0.01% 1820
2025
Q2
$335K Hold
34,545
﹤0.01% 1889
2025
Q1
$440K Sell
34,545
-617
-2% -$9.88K ﹤0.01% 1787
2024
Q4
$726K Sell
35,162
-315
-0.9% -$5.16K ﹤0.01% 1585
2024
Q3
$500K Hold
35,477
﹤0.01% 1783
2024
Q2
$443K Buy
35,477
+5,032
+17% +$61.1K ﹤0.01% 1788
2024
Q1
$404K Hold
30,445
﹤0.01% 1793
2023
Q4
$576K Hold
30,445
﹤0.01% 1603
2023
Q3
$458K Hold
30,445
﹤0.01% 1691
2023
Q2
$658K Hold
30,445
﹤0.01% 1515
2023
Q1
$856K Hold
30,445
0.01% 1306
2022
Q4
$770K Hold
30,445
0.01% 1357
2022
Q3
$877K Hold
30,445
0.01% 1264
2022
Q2
$771K Buy
+30,445
New +$877K 0.01% 1360

Other funds holding EMBC

MetLife Investment Management's EMBC Position: Q1 2026 in Review

MetLife Investment Management held its Embecta (EMBC) position steady in Q1 2026 at 33,168 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #2015.

MetLife Investment Management first reported a position in EMBC in Q2 2022 and has held it in 16 quarters since. The position peaked at $877K in Q3 2022. 337 funds tracked by Wall St. Rank hold EMBC as of Q1 2026.

  • MetLife Investment Management held 33,168 shares of Embecta worth $293K as of Q1 2026.
  • MetLife Investment Management left its Embecta share count unchanged in Q1 2026.
  • Embecta made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2015 holding.
  • MetLife Investment Management first reported a position in Embecta in Q2 2022 and has held it in 16 quarters since.
  • MetLife Investment Management's Embecta position peaked at $877K in Q3 2022.
  • 337 funds tracked by Wall St. Rank held Embecta as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.